David Mittelman

REPRESENTATIVE TRANSACTIONS $4 billion stock buyback and accelerated share repurchases by NYSE-listed transportation company $2 billion merger between two publicly-listed financial technology companies $950 million initial public offering by biopharma company onto the Nasdaq $600 million registered debt exchange offer by Nasdaq-listed biopharma company $550 million business combination among three publicly-traded financial institutions $280 million…